Johnson & Johnson on 8 Oct 2020 announced that the European Commission (EC), acting on behalf of the Europea...
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway has announced partnerships with five clinical sampl...
The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to de...
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and one of the leading pharmaceutical d...
COVAXX, a subsidiary of United Biomedical Inc (UBI) headquartered in the US, has announced the first healthy a...
Johnson & Johnson has announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for i...
The Australian Government has joined the COVAX facility, enabling the purchase of COVID-19 vaccine doses as they become ...
Researchers from Monash University in Australia and the National University of Singapore have adapted new cancer and pan...
Australia will invest almost $6 million in additional funding from the Medical Research Future Fund’s (MRFF) Coron...
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases,&n...
Vaxess Technologies, an innovative biotechnology company in the US developing the MIMIX smart release patch, has formed ...
Oxford university and AstraZeneca are to resume the international clinical trial of their proposed coronavirus vaccine c...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...
Intravacc, a global leader in translational research and development of viral and bacterial vaccines in the Netherlands,...
A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successf...
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, as a potential candidate for an emergency use authorization (EU...
Korea's LSK Global PS, a leading CRO to run Sinovac Phase III COVID-19 vaccine trial in Bangladesh. The company would m...
Beximco Pharmaceuticals Limited (BPL) in Bangladesh and the Serum Institute of India Pvt. Ltd (SII), have announced an a...
